Acquired Platelet Function Defect

What is Acquired Platelet Function Defect?

Acquired platelet function defects are diseases or conditions that cause the blood elements needed for blood clotting (platelets) to not work properly. The term "acquired" means these diseases or conditions are not inherited, but instead develop independently in a person.

Alternative names

Acquired qualitative platelet disorders; Acquired disorders of platelet function

Causes

With platelet disorders, there may be too many or too few platelets, or platelets that do not function well. Any platelet disorder affects blood clotting.

These disorders can be caused by diseases that are present at birth (congenital), or they may develop because of another disease or condition. In many cases, the platelet count may be normal or even high, but there will be evidence of a bleeding disorder.

Disorders that can cause problems in platelet function include:

• Chronic myelogenous leukemia
• Myelofibrosis
• Polycythemia vera
• Primary thrombocythemia

Other causes include:

• Kidney (renal) failure
• Multiple myeloma
• Medications such as aspirin, ibuprofen and other anti-inflammatory drugs, penicillins, phenothiazines, and prednisone (after long-term use)

Symptoms & Signs

• Abnormal color of urine (blood in the urine)
• Abnormal menstrual periods
  • Heavy menstrual periods
  • Prolonged menstrual bleeding (more than 5 days per menstrual period)
• Abnormal vaginal bleeding
• Bleeding under the skin or in the muscles (soft tissues)
• Gastrointestinal bleeding
  • Bloody, dark black, or tarry bowel movements
  • Vomiting blood or vomiting material that resembles coffee grounds
• Nosebleeds
• Prolonged bleeding, easy bruising
• Skin rash
  • Bruises
  • Pinpoint red spots (petechiae)

Exams and Tests

• Bleeding time
• Platelet aggregation test
• Platelet count
• PT and PTT

Treatments

Treatment is aimed at the cause of the problem.

• Bone marrow disorders (which have abnormally high numbers of platelets) are treated with platelet transfusions or by removing platelets from the blood and replacing them with donated platelets (plateletpheresis)
• Kidney failure is treated with dialysis or a drug called ddAVP
• Platelet problems caused by medication are treated by stopping the medication

Prognosis

Treating the cause of the problem usually corrects the defect.

Possible Complications

• Prolonged bleeding
• Severe anemia

When to contact a medical professional

Call your health care provider:

• If you have bleeding and do not know the cause
• If your symptoms get worse or do not improve after you are treated for an acquired platelet function defect

Prevention

Using medications carefully can reduce the risk of drug-related acquired platelet function defects. Treating other disorders may also reduce the risk. Some cases are not preventable.

References

McMillan R. Hemorrhagic disorders: Abnormalities of platelet and vascular function. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier;2007:chap 179.

Content provided by:

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

Review Date: .3/2/2009

Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.3/2/2009